Suchergebnisse
Filter
6 Ergebnisse
Sortierung:
Mayo's Impact on Patent Applications Related to Biotechnology, Diagnostics and Personalized Medicine
In: Mayo's impact on patent applications related to biotechnology, diagnostics and personalized medicine. / Aboy, Mateo; Crespo, Cristina; Liddell, Kathleen; Minssen, Timo; Liddicoat, Johnathan, Nature Biotechnology, Vol. 37, 05.2019, p. 513-518.
SSRN
One Year After Vanda, Are Diagnostics Patents Transforming Into Methods of Treatment to Overcome Mayo-Based Rejections?
In: One year after Vanda, are diagnostics patents transforming into methods of treatment to overcome Mayo-based rejections? / Aboy, Mateo; Crespo, Cristina; Liddell, Kathleen ; Davey, Neal; Liddicoat, Johnathan; Minssen, Timo., Nature Biotechnology, Vol. 38, 09.03.2020, p. 279–283.
SSRN
Repositioning Generic Drugs: Empirical Findings and Policy Implications
In: IIC - International Review of Intellectual Property and Competition Law, Band 53, Heft 9, S. 1287-1322
ISSN: 2195-0237
AbstractCommentators claim that drug repositioning (i.e. developing new uses for authorised drugs) significantly slows when generics are authorised and, therefore, law reform is necessary to encourage more R&D. This study empirically examines this claim by analysing records of clinical trials. It finds that once generics are authorised: (i) commercial trials continue at "active" rates for approximately half of the drugs studied, and (ii) the number of hospital and university trials actually increases. These findings cast doubt on whether additional incentives are needed. They also indicate that a more effective way to reposition drugs is for recently established government programmes to embrace IP strategies and leverage the hospital and university trials as an R&D pipeline.
Repositioning Generic Drugs: Empirical Findings and Policy Implications
In: International Review of Intellectual Property & Competition Law | 53, pages 1287–1322 (2022)
SSRN
How Does Emerging Patent Case Law in the US and Europe Affect Precision Medicine? How Will Today's Patent Law Affect Tomorrow's Innovation in the Areas of Biomarkers and Nature-Based Products; Diagnostics; and Algorithms, Big Data and AI?
In: Aboy, M., Liddell, K., Crespo, C. et al. How does emerging patent case law in the US and Europe affect precision medicine?. Nat Biotechnol 37, 1118–1125 (2019)
SSRN